Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-25 of 25 for

Edit search filters
  1. A Study to Evaluate Diagnostic Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® in Patients Scheduled for a Liver Biopsy

    Rochester, MN

  2. A Study of the Frequency of Hepatitis B, Hepatitis C, and Hepatocellular Carcinoma Among Minnesota's African Immigrants, and Their Knowledge of the Diseases.

    Rochester, MN

  3. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C

    Rochester, MN

  4. A Registry to Form a Long-Term Therapeutic and Research Network for Hepatitis C

    Jacksonville, FL

  5. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection

    Rochester, MN

.

Mayo Clinic Footer